BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3180613)

  • 1. Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level.
    Miller JH; Marcus CS
    Clin Nucl Med; 1988 Sep; 13(9):652-3. PubMed ID: 3180613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Dadparvar S; Krishna L; Brady LW; Slizofski WJ; Brown SJ; Chevres A; Micaily B
    Cancer; 1993 Jun; 71(11):3767-73. PubMed ID: 8490927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma].
    Abduluakhab M; Gavrilov M; Mladenov B
    Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of 18F FDG-PET in patients with suspicion of recurrent differentiated thyroid cancer by elevated antithyroglobulin antibodies levels and negative ¹³¹I scan].
    Sanz Viedma S; Borrego Dorado I; Rodríguez Rodríguez JR; Navarro González E; Vázquez Albertino R; Fernández López R; Agudo Martínez A
    Rev Esp Med Nucl; 2011; 30(2):77-82. PubMed ID: 21334773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
    Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
    J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
    Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
    An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
    [No Abstract]   [Full Text] [Related]  

  • 9. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
    Arning G; Ehrenheim C; Schober O; Hundeshagen H
    Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels.
    Pachón-Garrudo VM; Cuenca-Cuenca JI; Ruiz-Franco-Baux J; Borrego-Dorado I; Tirado-Hospital JL; Navarro-González E; Vázquez-Albertino R
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):315-21. PubMed ID: 23084014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
    Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
    J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy.
    Kalender E; Zeki Celen Y; Elboga U; Deniz Demir H; Yilmaz M
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):328-31. PubMed ID: 23084016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas].
    Degrossi OJ; Rozados IB; Damilano S; Degrossi EB; de Ganino L; Pinkas M; García del Río H; Artagaveytía D
    Medicina (B Aires); 1991; 51(4):291-5. PubMed ID: 1821916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of thyroglobulin as a tumor marker in the serum of patients with differentiated thyroid carcinoma: longitudinal and cross-sectional studies (author's transl)].
    Schatz H; Grebe S; Mäser E; Teuber J; Horn W; Schröder O; Schatz C
    Klin Wochenschr; 1982 May; 60(9):457-64. PubMed ID: 7045510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values].
    Müller-Gärtner HW; Schneider C; Tempel MT
    Nuklearmedizin; 1986 Oct; 25(5):194-200. PubMed ID: 3797259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
    J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tc-99m MIBI SPECT in detecting metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Hsu CH; Liu FY; Yen RF; Kao CH
    Endocr Res; 2003 Feb; 29(1):9-15. PubMed ID: 12665314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.